These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 16883539
1. [Relationship between PAI-1 gene 4G/5G polymorphism and clinical profile of IgA nephropathy]. Ding R, Chen XM, Liu SW, Lv Y, Wu J. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):449-51. PubMed ID: 16883539 [Abstract] [Full Text] [Related]
2. [Relationship between plasminogen activator inhibitor-1 gene 4G/5G polymorphism and type 2 diabetic nephropathy in Chinese Han patients in Guangdong Province]. Liu SQ, Xue YM, Yang GC, He FY, Zhao XS. Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):904-7. PubMed ID: 15321757 [Abstract] [Full Text] [Related]
3. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction. Fu L, Jin H, Song K, Zhang C, Shen J, Huang Y. Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311 [Abstract] [Full Text] [Related]
8. [Genetic variations in plasminogen activator inhibitor-1 gene and beta fibrinogen gene associated with glomerular microthrombosis in lupus nephritis and the gene dosage effect]. Gong R, Liu Z, Chen Z, Li L. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):1-5. PubMed ID: 11836675 [Abstract] [Full Text] [Related]
10. Close relationship of plasminogen activator inhibitor-1 4G/5G polymorphism and progression of IgA nephropathy. Suzuki H, Sakuma Y, Kanesaki Y, Eiro M, Asahi K, Sanada H, Watanabe K, Katoh T, Watanabe T. Clin Nephrol; 2004 Sep; 62(3):173-9. PubMed ID: 15481848 [Abstract] [Full Text] [Related]
12. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis. Emingil G, Berdeli A, Gürkan A, Han Saygan B, Köse T, Atilla G. J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155 [Abstract] [Full Text] [Related]
13. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history. Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS. Prostate; 2007 Feb 01; 67(2):172-7. PubMed ID: 17044080 [Abstract] [Full Text] [Related]
14. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity. Castelló R, España F, Vázquez C, Fuster C, Almenar SM, Aznar J, Estellés A. Thromb Res; 2006 Feb 01; 117(5):487-92. PubMed ID: 15907980 [Abstract] [Full Text] [Related]
15. The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children. Kinik ST, Ataç FB, Verdi H, Cetintaş S, Sahin FI, Ozbek N. Clin Endocrinol (Oxf); 2005 May 01; 62(5):607-10. PubMed ID: 15853833 [Abstract] [Full Text] [Related]
17. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer. Eroglu A, Ulu A, Cam R, Akar N. J BUON; 2006 May 01; 11(4):481-4. PubMed ID: 17309181 [Abstract] [Full Text] [Related]
19. PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma. Choi JW, Lee JH, Park HS, Kim YS. J Clin Pathol; 2011 Oct 01; 64(10):893-7. PubMed ID: 21725041 [Abstract] [Full Text] [Related]
20. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression. Ramón LA, Gilabert-Estellés J, Cosín R, Gilabert J, España F, Castelló R, Chirivella M, Romeu A, Estellés A. Thromb Res; 2008 Oct 01; 122(6):854-60. PubMed ID: 18423526 [Abstract] [Full Text] [Related] Page: [Next] [New Search]